Paper40397291
Exploring the therapeutic potential of annexin A1-derived peptide Ac2-26 in modulating NLRP3 inflammasome activation in Crohn's disease.
Lice I and 8 others. Mol Cell Biochem, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Exploring the therapeutic potential of annexin A1-derived peptide Ac2-26 in modulating NLRP3 inflammasome activation in Crohn's disease. Papers, record 40397291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40397291
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the therapeutic potential of annexin A1-derived peptide Ac2-26 in modulating NLRP3 inflammasome activation in Crohn's disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Crohn Disease | Major topic |
| Annexin A1 | Major topic |
| Inflammasomes | Major topic |
| Peptides | Major topic |
| Humans | |
| Caco-2 Cells | |
| Male | |
| Female | |
| Adult | |
| Receptors, Formyl Peptide | |
| Receptors, Lipoxin |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21/01541-1 | Fundação de Amparo à Pesquisa do Estado de São Paulo | PubMed | ||
| 21/06059-3 | Fundação de Amparo à Pesquisa do Estado de São Paulo | PubMed | ||
| 20/03565-2 | Fundação de Amparo à Pesquisa do Estado de São Paulo | PubMed | ||
| 88881.310737/2018-01 | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | PubMed | ||
| 308524/2022-5 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38198110 | Lack of Annexin A1 Exacerbates Inflammatory Response in Acute Endometritis Model. | Inflammation | 2024 | https://conductscience.org/library/papers/38198110 | PubMed |
| 2 | 35603196 | Annexin-A1 Tripeptide Attenuates Surgery-Induced Neuroinflammation and Memory Deficits Through Regulation the NLRP3 Inflammasome. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603196 | PubMed |
| 3 | 15472519 | Annexin 1 is secreted in situ during ulcerative colitis in humans. | Inflamm Bowel Dis | 2004 | https://conductscience.org/library/papers/15472519 | PubMed |
| 4 | 37566893 | Overview of Biosimilars in Inflammatory Bowel Diseases. | Am J Gastroenterol | 2024 | https://conductscience.org/library/papers/37566893 | PubMed |
| 5 | 22488912 | Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. | Inflamm Bowel Dis | 2012 | https://conductscience.org/library/papers/22488912 | PubMed |
| 6 | 27993998 | The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans. | J Crohns Colitis | 2017 | https://conductscience.org/library/papers/27993998 | PubMed |
| 7 | 37190040 | The Multifaceted Role of Annexin A1 in Viral Infections. | Cells | 2023 | https://conductscience.org/library/papers/37190040 | PubMed |
| 8 | 20168318 | NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20168318 | PubMed |
| 9 | 32283822 | Annexin A1 Regulates NLRP3 Inflammasome Activation and Modifies Lipid Release Profile in Isolated Peritoneal Macrophages. | Cells | 2020 | https://conductscience.org/library/papers/32283822 | PubMed |
| 10 | 23774107 | Innate and adaptive immunity in inflammatory bowel disease. | Autoimmun Rev | 2014 | https://conductscience.org/library/papers/23774107 | PubMed |
| 11 | 19845684 | Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19845684 | PubMed |
| 12 | 20303296 | The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. | Immunity | 2010 | https://conductscience.org/library/papers/20303296 | PubMed |
| 13 | 25690650 | Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke. | FASEB J | 2015 | https://conductscience.org/library/papers/25690650 | PubMed |
| 14 | 16675446 | Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16675446 | PubMed |
| 15 | 37891214 | Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn's disease from ulcerative colitis. | Sci Rep | 2023 | https://conductscience.org/library/papers/37891214 | PubMed |
| 16 | 30650525 | Lack of Endogenous Annexin A1 Increases Mast Cell Activation and Exacerbates Experimental Atopic Dermatitis. | Cells | 2019 | https://conductscience.org/library/papers/30650525 | PubMed |
| 17 | 24280937 | Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. | Mucosal Immunol | 2014 | https://conductscience.org/library/papers/24280937 | PubMed |
| 18 | 27995621 | Annexin A1 promotes timely resolution of inflammation in murine gout. | Eur J Immunol | 2017 | https://conductscience.org/library/papers/27995621 | PubMed |
| 19 | 23241962 | Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23241962 | PubMed |
| 20 | 33114438 | Cellular Function of Annexin A1 Protein Mimetic Peptide Ac2-26 in Human Skin Keratinocytes HaCaT and Fibroblast Detroit 551 Cells. | Nutrients | 2020 | https://conductscience.org/library/papers/33114438 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA1 | 301 | PubTator's text mining | https://conductscience.org/library/genes/301 | NCBI Gene |
| FPR1 | 2357 | PubTator's text mining | https://conductscience.org/library/genes/2357 | NCBI Gene |
| FPR2 | 2358 | PubTator's text mining | https://conductscience.org/library/genes/2358 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| OCLN | 100506658 | PubTator's text mining | https://conductscience.org/library/genes/100506658 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40397291
GET https://conductscience.org/api/papers/v1/40397291/references?page=2